4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-013038
CHIEF MEDICAL OFFICER sold 400 shares at $17.53 ($7,012)
- CHIEF MEDICAL OFFICER gave up 1,241 shares (to pay taxes)
- CHIEF MEDICAL OFFICER acquired 4,623 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-01 | Option exercise 10b5-1 | +2,498 | 44,408 | D | ||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-01 | Shares withheld for taxes 10b5-1 | −734 | $17.76 | $13,036 | 43,674 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-02 | Option exercise 10b5-1 | +1,725 | 45,399 | D | ||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-02 | Shares withheld for taxes 10b5-1 | −507 | $17.76 | $9,004 | 44,892 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-05 | Option exercise 10b5-1 | +400 | $1.86 | $744 | 45,292 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-05 | Sale 10b5-1 | −400 | $17.53 | $7,012 | 44,892 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-01 | Option exercise · Restricted Share Unit 10b5-1 | −2,498 | 7,492 | D | ||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-01 | Grant or award · Restricted Share Unit 10b5-1 | +6,496 | 6,496 | D | ||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-01 | Grant or award · Share Option 10b5-1 | +38,974 | 38,974 | D | ||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-02 | Option exercise · Restricted Share Unit 10b5-1 | −1,725 | 3,450 | D | ||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-09-05 | Option exercise · Share Option 10b5-1 | −400 | 139,817 | D | ||
| Open-market sales · 400 sh · avg $17.53 · $7,012 | |||||||
Loading xslF345X05/form4-09062023_110943.xml…